[go: up one dir, main page]

WO2006137751A3 - Procedes, utilisations et compositions destines a la detection d'une predisposition accrue ou reduite a divers cancers par identification de genotypes specifiques du gene cyp1b1 - Google Patents

Procedes, utilisations et compositions destines a la detection d'une predisposition accrue ou reduite a divers cancers par identification de genotypes specifiques du gene cyp1b1 Download PDF

Info

Publication number
WO2006137751A3
WO2006137751A3 PCT/PL2006/000040 PL2006000040W WO2006137751A3 WO 2006137751 A3 WO2006137751 A3 WO 2006137751A3 PL 2006000040 W PL2006000040 W PL 2006000040W WO 2006137751 A3 WO2006137751 A3 WO 2006137751A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
compositions
identification
detection
increased
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/PL2006/000040
Other languages
English (en)
Other versions
WO2006137751A2 (fr
Inventor
Joanna Matyjasik
Jan Lubinski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pomeranian Academy of Medicine
Original Assignee
Pomeranian Academy of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PL375857A external-priority patent/PL214855B1/pl
Application filed by Pomeranian Academy of Medicine filed Critical Pomeranian Academy of Medicine
Priority to EP06769504A priority Critical patent/EP1922417A2/fr
Priority to PCT/PL2006/000062 priority patent/WO2007148997A1/fr
Priority to PL06784044T priority patent/PL2134876T3/pl
Priority to EP06784044.7A priority patent/EP2134876B1/fr
Priority to RU2009127735/10A priority patent/RU2470998C2/ru
Publication of WO2006137751A2 publication Critical patent/WO2006137751A2/fr
Anticipated expiration legal-status Critical
Publication of WO2006137751A3 publication Critical patent/WO2006137751A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La présente invention concerne des procédés, des utilisations et des compositions utiles dans le diagnostic des prédispositions aux cancers humains de divers sites, les variants constitutionnels d'altérations dans le gène CYPlBl étant analysés dans une matière biologique du patient examiné. Ce mode peut être appliqué pour l'examen de personnes d'origine polonaise et probablement aussi d'autres groupes ethniques.
PCT/PL2006/000040 2005-06-23 2006-06-22 Procedes, utilisations et compositions destines a la detection d'une predisposition accrue ou reduite a divers cancers par identification de genotypes specifiques du gene cyp1b1 Ceased WO2006137751A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP06769504A EP1922417A2 (fr) 2005-06-23 2006-06-22 Procedes, utilisations et compositions destines a la detection d'une predisposition accrue ou reduite a divers cancers par identification de genotypes specifiques du gene cyp1b1
PCT/PL2006/000062 WO2007148997A1 (fr) 2006-06-22 2006-09-06 Détermination de la prédisposition au cancer par l'identification de combinaisons génotypiques de variants spécifiques des gènes cyp1b1, brca2 et chek2
PL06784044T PL2134876T3 (pl) 2006-06-22 2006-09-06 Określanie predyspozycji do raka piersi poprzez identyfikację kombinacji genotypu specyficznych wariantów genów CYP1B1, BRCA2 oraz CHEK2
EP06784044.7A EP2134876B1 (fr) 2006-06-22 2006-09-06 DÉTERMINATION DE LA PRÉDISPOSITION AU CANCER Du SEIN PAR L'IDENTIFICATION DE COMBINAISONS GÉNOTYPIQUES DE VARIANTS SPÉCIFIQUES DES GÈNES CYP1B1, BRCA2 ET CHEK2
RU2009127735/10A RU2470998C2 (ru) 2006-06-22 2006-09-06 Определение предрасположенности к раку путем идентификации генотипических комбинаций специфичных вариантов генов cyp1b1, brca2 и снек2

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US69314905P 2005-06-23 2005-06-23
PL375857A PL214855B1 (pl) 2005-06-23 2005-06-23 Sposób wykrywania genetycznie uwarunkowanej predyspozycji do nowotworów różnych narządów poprzez identyfikację wariantu genu CYP1B1 oraz zastosowania obejmujące taką zmianę
PLP375857 2005-06-23
US60/693,149 2005-06-23

Publications (2)

Publication Number Publication Date
WO2006137751A2 WO2006137751A2 (fr) 2006-12-28
WO2006137751A3 true WO2006137751A3 (fr) 2008-04-17

Family

ID=37507792

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/PL2006/000040 Ceased WO2006137751A2 (fr) 2005-06-23 2006-06-22 Procedes, utilisations et compositions destines a la detection d'une predisposition accrue ou reduite a divers cancers par identification de genotypes specifiques du gene cyp1b1

Country Status (2)

Country Link
EP (1) EP1922417A2 (fr)
WO (1) WO2006137751A2 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002004683A2 (fr) * 2000-07-11 2002-01-17 Vanderbilt University Methode de detection d'une sensibilite accrue au cancer du sein
WO2002030951A2 (fr) * 2000-10-13 2002-04-18 Genaissance Pharmaceuticals, Inc. Haplotypes du gene cyp1b1

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002004683A2 (fr) * 2000-07-11 2002-01-17 Vanderbilt University Methode de detection d'une sensibilite accrue au cancer du sein
WO2002030951A2 (fr) * 2000-10-13 2002-04-18 Genaissance Pharmaceuticals, Inc. Haplotypes du gene cyp1b1

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
SASAKI M. ET AL.,: "polymorphisms of the cyp1b1 gene as risk factors for human renal cell cancer", CLINICAL CANCER RESEARCH, vol. 10, 15 March 2004 (2004-03-15), pages 2015 - 2019, XP002412158 *
WANQING WEN ET AL.,: "cytochrome p450 1b1 and catechol-o-methyltransferase genetic polymorphisms and breast cancer risk in chinese women: results from shanghai breast cancer study and a meta-analysis", CANCER EPIDEMIOLOGY, BIOMARKERS & PREVENTION, vol. 14, no. 2, February 2005 (2005-02-01), pages 329 - 335, XP002412157 *
WATANABE J. ET AL.,: "association of cyp1b1 genetic polymorphism with incidence to breast and lung cancer", PHARMACOGENETICS, vol. 10, 2000, pages 25 - 33, XP009076429 *

Also Published As

Publication number Publication date
WO2006137751A2 (fr) 2006-12-28
EP1922417A2 (fr) 2008-05-21

Similar Documents

Publication Publication Date Title
WO2009077864A3 (fr) Compositions et procédés de détection d'anticorps tiab
WO2009009752A3 (fr) Modèles génétiques pour le classement des risques de cancer
WO2007109236A3 (fr) Empreintes digitales micro-arn pendant une mégacaryocytopoïese
WO2008021515A3 (fr) Méthodes de détermination des niveaux d'acides aminés libres et de dipeptides et de diagnostic de la maladie d'alzheimer
AU2002303444A1 (en) Detection of microsatellite instability and its use in diagnosis of tumors
AU2013207599A1 (en) Process for determining one or more analytes in samples of biological origin having complex composition, and use thereof
WO2006127861A3 (fr) Diagnostic de maladies et d'etats pathologiques par l'analyse d'echantillons biologiques traites par voie histopathologique a l'aide de preparations tissulaires liquides
WO2010028373A3 (fr) Procédés pour diagnostiquer le cancer et déterminer la survie globale et la survie sans maladie des patients atteints du cancer
EP2589961A3 (fr) Diagnostic et classification moléculaires de mélanome malin
WO2005040421A3 (fr) Marqueurs de pronostic et de diagnostic des troubles de proliferation cellulaire dans les tissus mammaires
WO2007028161A3 (fr) Procédés et compositions permettant d’identifier des biomarqueurs utiles au diagnostic et/ou au traitement d’états biologiques
WO2007150044A3 (fr) Modèles génétiques utilisés pour la stratification des risques de cancer
AU2010202926B2 (en) Markers and methods relating to the assessment of Alzheimer's disease
WO2006086242A3 (fr) Biomarqueurs de l'osteoarthrite benigne et utilisations
WO2007016532A3 (fr) Mutations et polymorphismes de hdac4
WO2007109733A3 (fr) Marqueurs de diagnostic et de pronostic et strategies de traitement de la sclerose en plaques
WO2010033951A3 (fr) Procédé d'identification et de prédiction de la sclérose en plaques et de la réponse à la thérapie
MX2009001070A (es) Uso de proteina con actividad inhibidora de melanoma (mia) como un indicador temprano para la respuesta terapeutica en melanoma.
WO2008055225A3 (fr) Systèmes et procédés permettant de mesurer in vivo une activité biologique, des processus et/ou des compositions interstitiels
WO2006121710A3 (fr) Biomarqueurs du cancer de la vessie et utilisations
WO2005024067A3 (fr) Analyse genetique permettant une stratification du risque de cancer
WO2006130527A3 (fr) Mutations et polymorphismes de recepteur du facteur de croissance 1 des fibroblastes
WO2010009440A3 (fr) Génotypage rhd foetal non invasif à partir de sang maternel entier
WO2009016231A3 (fr) Compositions et procédés permettant de détecter des troubles liés à l'histamine
WO2006137751A3 (fr) Procedes, utilisations et compositions destines a la detection d'une predisposition accrue ou reduite a divers cancers par identification de genotypes specifiques du gene cyp1b1

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2006769504

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 06769504

Country of ref document: EP

Kind code of ref document: A2